329 related articles for article (PubMed ID: 2782977)
1. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up.
Kyle V; Cawston TE; Hazleman BL
Ann Rheum Dis; 1989 Aug; 48(8):667-71. PubMed ID: 2782977
[TBL] [Abstract][Full Text] [Related]
2. Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis.
Pountain GD; Calvin J; Hazleman BL
Br J Rheumatol; 1994 Jun; 33(6):550-4. PubMed ID: 8205403
[TBL] [Abstract][Full Text] [Related]
3. Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis.
Park JR; Jones JG; Hazleman BL
Ann Rheum Dis; 1981 Oct; 40(5):493-5. PubMed ID: 6171213
[TBL] [Abstract][Full Text] [Related]
4. Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations.
Salvarani C; Macchioni P; Boiardi L; Rossi F; Casadei Maldini M; Mancini R; Beltrandi E; Spacca C; Lodi L; Portioli I
J Rheumatol; 1992 Jul; 19(7):1100-6. PubMed ID: 1512765
[TBL] [Abstract][Full Text] [Related]
5. Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months.
Kyle V; Hazleman BL
Ann Rheum Dis; 1989 Aug; 48(8):658-61. PubMed ID: 2782975
[TBL] [Abstract][Full Text] [Related]
6. Serum amyloid A concentrations in giant-cell arteritis and polymyalgia rheumatica: a useful test in the management of the disease.
Hachulla E; Saile R; Parra HJ; Hatron PY; Gosset D; Fruchart JC; Devulder B
Clin Exp Rheumatol; 1991; 9(2):157-63. PubMed ID: 1711943
[TBL] [Abstract][Full Text] [Related]
7. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis.
Kermani TA; Schmidt J; Crowson CS; Ytterberg SR; Hunder GG; Matteson EL; Warrington KJ
Semin Arthritis Rheum; 2012 Jun; 41(6):866-71. PubMed ID: 22119103
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study.
Cantini F; Salvarani C; Olivieri I; Macchioni L; Ranzi A; Niccoli L; Padula A; Boiardi L
Semin Arthritis Rheum; 2000 Aug; 30(1):17-24. PubMed ID: 10966209
[TBL] [Abstract][Full Text] [Related]
9. The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome.
Ellis ME; Ralston S
Ann Rheum Dis; 1983 Apr; 42(2):168-70. PubMed ID: 6847261
[TBL] [Abstract][Full Text] [Related]
10. The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis.
Jakobsson K; Jacobsson L; Mohammad AJ; Nilsson JÅ; Warrington K; Matteson EL; Turesson C
BMC Musculoskelet Disord; 2016 Aug; 17(1):363. PubMed ID: 27558589
[TBL] [Abstract][Full Text] [Related]
11. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
[TBL] [Abstract][Full Text] [Related]
12. Giant cell arteritis with an erythrocyte sedimentation rate lower than 50.
Martínez-Taboada VM; Blanco R; Armona J; Uriarte E; Figueroa M; Gonzalez-Gay MA; Rodriguez-Valverde V
Clin Rheumatol; 2000; 19(1):73-5. PubMed ID: 10752506
[TBL] [Abstract][Full Text] [Related]
13. CD8+ lymphocyte subset in polymyalgia rheumatica and arteritis temporalis. Inverse relationship between the acute hepatic phase reactants and the CD8+ T-cell subset.
Elling H; Elling P; Olsson A
Clin Exp Rheumatol; 1989; 7(6):627-30. PubMed ID: 2533002
[TBL] [Abstract][Full Text] [Related]
14. Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data.
Pamuk ON; Dönmez S; Karahan B; Pamuk GE; Cakir N
Clin Exp Rheumatol; 2009; 27(5):830-3. PubMed ID: 19917168
[TBL] [Abstract][Full Text] [Related]
15. Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica.
van der Geest KS; Abdulahad WH; Rutgers A; Horst G; Bijzet J; Arends S; Roffel MP; Boots AM; Brouwer E
Rheumatology (Oxford); 2015 Aug; 54(8):1397-402. PubMed ID: 25724206
[TBL] [Abstract][Full Text] [Related]
16. Plasma adrenomedullin levels in patients with polymyalgia rheumatica and giant cell arteritis.
Garcia-Unzueta MT; Martínez-Taboada VM; Amado-Señarís JA; Rodríguez-Valverde V
Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S6-9. PubMed ID: 16859588
[TBL] [Abstract][Full Text] [Related]
17. Serum C-reactive protein in polymyalgia rheumatica. A prospective serial study.
Mallya RK; Hind CR; Berry H; Pepys MB
Arthritis Rheum; 1985 Apr; 28(4):383-7. PubMed ID: 2859021
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic difficulties in polymyalgia rheumatica cases with normal erythrocyte sedimentation rate and C-reactive protein values.
Kara M; Alp G; Koç AM
Medicine (Baltimore); 2023 Sep; 102(39):e35385. PubMed ID: 37773830
[TBL] [Abstract][Full Text] [Related]
19. Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.
van Sleen Y; Graver JC; Abdulahad WH; van der Geest KSM; Boots AMH; Sandovici M; Brouwer E
Front Immunol; 2019; 10():1981. PubMed ID: 31507597
[TBL] [Abstract][Full Text] [Related]
20. [C-reactive protein or blood sedimentation reaction os preventive studies in the physician's laboratory?].
Steiner A; Vetter W
Ther Umsch; 1995 May; 52(5):350-4. PubMed ID: 7770822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
